Biospace shared the summary of Clarivate Analytics’ report “Cortellis Drugs to Watch,” in which seven new drugs identified as blockbusters by 2023, here is the list; #1. AbbVie’s Upadacitinib. On December 20, 2018, AbbVie submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA)and a marketing authorization application (MAA) to the European Medicines Agency (EMA)for…